/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
CYP2C19 loss-of-function alleles and the use of omeprazole or esomeprazole increase the risk of cardiovascular outcomes in patients using clopidogrel - a real-world study
Event: ESC Congress 2022
Topic: Pharmacogenetics
Session: Short and long-term antiplatelet therapy in clinical practice
ESC 365 is supported by
